CTY
City Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.46
−4.20%Margins
Gross margin
66.0%
EBITDA margin
55.2%
EBIT margin
43.6%
Net margin
27.7%
FCF margin
33.4%
17.7%
Return on equity
9.2%
Return on assets
19.2%
Return on invested capital
0.33x
Asset turnover
$3.3B
Cash from operations
$0.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2020